SkyePharma_NN
annual_JJ
report_NN
2002_CD
Consolidated_NN
statement_NOMZ
of_PIN
total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
Year_NN
to_PIN
Year_NN
to_PIN
31_CD
December_NN
2002_CD
31_CD
December_NN
2001 000 000_CD
Profit_NN
loss_NN
attributable_JJ
to_PIN
shareholders_NN
1,109_CD
9,452_CD
Net_JJ
currency_NN
translation_NOMZ
effect_NN
903_CD
28_CD
Lapse_NN
of_PIN
warrants_NN
1,096_CD
271_CD
Total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
for_PIN
the_DT
year_NN
3,108_CD
9,153_CD
As_IN
described_VBN
in_PIN
note_NN
22a_NN
:_:
Share_NN
Capital_NN
,_,
the_DT
B_NN
Warrants_NN
relating_VBG [WZPRES]
to_PIN
the_DT
acquisition_NOMZ
of_PIN
Krypton_NN
lapsed_VBD
on_PIN
31_CD
December_NN
2002_CD
._.
The_DT
fair_JJ
value_NN
of_PIN
the_DT
lapsed_VBN
warrants_NN
of_PIN
1,096,000_CD
has_VPRT [PEAS]
been_VBN [PASS]
transferred_VBN
from_PIN
non-distributable_JJ
reserves_NN
to_TO
retained_VBN
profits_NN
._.
In_PIN
2001_CD
the_DT
class_NN
C_NN
Warrants_NN
relating_VBG [WZPRES]
to_PIN
the_DT
debenture_NN
issue_NN
lapsed_VBD
._.
The_DT
fair_JJ
value_NN
of_PIN
the_DT
warrants_NN
at_PIN
issue_NN
of_PIN
271,000_CD
was_VBD [PASS]
transferred_VBN
from_PIN
non-distributable_JJ
reserves_NN
to_TO
retained_VBN
profits_NN
._.
The_DT
lapse_NN
of_PIN
warrants_NN
represents_VPRT
a_DT
transfer_NN
of_PIN
value_NN
from_PIN
the_DT
warrant_NN
holders_NN
to_TO
existing_VBG
shareholders_NN
._.
In_PIN
accordance_NN
with_PIN
FRS4_NN
:_:
Capital_NN
instruments_NOMZ
,_,
this_DEMP
is_VPRT [PASS]
shown_VBN [PRIV]
as_IN
a_DT
recognized_VBN [PRIV]
gain_NN
,_,
although_CONC
total_JJ
shareholders_NN
funds_NN
remain_VPRT
unchanged_JJ
._.
Reconciliation_NOMZ
of_PIN
movements_NOMZ
in_PIN
shareholders_NN
funds_NN
Year_NN
to_PIN
Year_NN
to_PIN
31_CD
December_NN
2002_CD
31_CD
December_NN
2001 000 000_CD
Shareholders_NN
funds_NN
at_PIN
the_DT
beginning_GER
of_PIN
the_DT
year_NN
95,145_CD
68,952_CD
Total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
for_PIN
the_DT
year_NN
3,108_CD
9,153_CD
Goodwill_NN
adjustments_NOMZ
on_PIN
deferred_JJ
consideration_NOMZ
4,837_CD
148_CD
Equity_NOMZ
shares_NN
issued_VBD
allocated_VBN
,_,
net_NN
of_PIN
expenses_NN
43,816_CD
29,599_CD
Exercise_NN
of_PIN
share_NN
options_NOMZ
,_,
net_NN
of_PIN
expenses_NN
700_CD
459_CD
Non-equity_JJ
shares_NN
converted_VBD
to_PIN
equity_NOMZ
shares_NN
11,310_CD
Decrease_NN
increase_NN
in_PIN
shares_NN
and_PHC
warrants_NN
to_TO
be_VB [PASS]
issued_VBN
5,780_CD
5,780_CD
Revaluation_NOMZ
of_PIN
shares_NN
and_PHC
warrants_NN
to_TO
be_VB [PASS]
issued_VBN
4,837_CD
148_CD
Issue_NN
of_PIN
warrants_NN
311_CD
Exercise_NN
of_PIN
warrants_NN
624_CD
56_CD
Lapse_NN
of_PIN
warrants_NN
1,096_CD
436_CD
Net_JJ
movement_NOMZ
in_PIN
the_DT
year_NN
29,125_CD
26,193_CD
Shareholders_NN
funds_NN
at_PIN
the_DT
end_NN
of_PIN
the_DT
year_NN
124,270_CD
95,145_CD
consolidated_JJ
statement_NOMZ
of_PIN
total_JJ
51_CD
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
reconciliation_NOMZ
of_PIN
movements_NOMZ
in_PIN
shareholders_NN
funds_NN
